Expanded Indications for Cerapedics’ PearlMatrix P-15
PearlMatrix is now the only Class III drug/device spinal graft approved for all major lumbar interbody surgical approaches in addition...
PearlMatrix is now the only Class III drug/device spinal graft approved for all major lumbar interbody surgical approaches in addition...
The shelf life of the rhNELL-1 differentiated bone growth factor product has been extended to 24 months....
Study results demonstrated that PearlMatrix achieved superior clinical success and time-to-fusion at 24 months compared to local autograft....
The product is designed to more closely mimic the structure of human bone, increase the graft's surface area, improve osteoconductivity,...
The pilot program addresses a critical evidence gap in emerging regenerative medicine treatments for 32.5 million Americans with knee OA....
During 510(k) application review, it has become clear that if granted market authorization, CERAMENT V may come to establish an...
The prospective, randomized, single-blinded, controlled, multi-center study will assess MagnetOs vs. autograft in hindfoot or ankle fusions....
STIMULAN Rapid Cure calcium matrix can now be used with both a wider range of antibiotics and also with antifungals...
Made with Citregen and bioactive glass, Citregraft is a highly porous bioactive synthetic product designed to interact with proteins to...
The synthetic, absorbable gel is for use as an adjunct in lumbar spine surgery for the reduction of leg pain...
Login
Register for a free account
As a guest member you get access to more articles and videos every month.